Read More Pharma Industry News Why did Newron Pharmaceuticals stock rise by nearly 8% and what triggered investor enthusiasm? Newron Pharmaceuticals stock rallies 7.88% after evenamide schizophrenia trial data and WCBP presentations highlight breakthrough potential. Read what’s next for investors. byPallavi MadhirajuSeptember 7, 2025